Business
Bionano Genomics Announces Global User Event at Bionano Laboratories Before American Society of Human Genetics (ASHG) Annual Meeting
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the company will host a “Meet the User” event today, October
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the company will host a “Meet the User” event today, October 24, 2022, at its new CLIA-certified Bionano Laboratories facility in advance of the American Society of Human Genetics (ASHG) Annual Meeting 2022. The event is the first scientific user meeting in the company’s history to bring together researchers curious about optical genome mapping (OGM) and experienced users, enabling practical and hands-on experience with different aspects of the OGM workflow, including sample selection, DNA isolation, labeling, data collection and reporting. Over 50 Bionano customers and prospects from countries including Canada, France, Lebanon, Sweden, Germany, India and Mexico will gather for constitutional, hematologic and cell bioprocessing case presentations, demonstrations of Bionano’s Saphyr® system and NxClinical™ software, and user focus groups. The day’s programming will include a tour of the state-of-the-art Bionano Laboratories, with a hands-on demonstration of the OGM workflow by experienced technologists. Expert Bionano scientists and renowned researchers, including Dr. Adam Smith from University Health Network and Dr. Nikhil Sahajpal, fellow at Greenwood Genetic Center, will lead educational sessions focused on data analysis of rare undiagnosed diseases and hematologic malignancy cases. Researchers from hospitals and medical institutions including MD Anderson Cancer Center, Children’s Hospital Los Angeles and Boston Children’s Hospital will share their experience and approaches for OGM implementation in their laboratories for various research applications studying genetic diseases. Bionano’s chief operating officer, Mark Oldakowski, will also present an overview of the company’s product roadmap. “Our user meeting is a terrific opportunity to showcase Bionano Laboratories to our customers and interested prospects. The day’s programming will include practical insights and real-world use cases from our on-site OGM experts and visiting OGM users, as well as a discussion of research problems and networking opportunities. This event is an important milestone for Bionano and demonstrates the increased adoption of and interest in OGM across the world,” commented Dr. Alka Chaubey, chief medical officer of Bionano Genomics. “Bionano is excited ...